Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04058249 · ClinicalTrials.gov registry record · NA
Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT04058249: Clinical Trial NA study, sponsored by Stanford University.
NCT04058249 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04058249, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of an accelerated schedule of theta-burst stimulation for treating manic episodes in bipolar disorder. In this open-label study, all participants will receive accelerated theta-burst stimulation.
Interventions
- DEVICE Accelerated intermittent theta-burst stimulation over right DLPFC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04058249
The ClinicalTrials.gov registry entry for NCT04058249 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Accelerated intermittent theta-burst stimulation over right DLPFC is the first listed.
NCT04058249 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04058249 about?
NCT04058249 is a clinical study titled "Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder". This study evaluates the efficacy of an accelerated schedule of theta-burst stimulation for treating manic episodes in bipolar disorder. In this open-label study, all participants will receive accelerated theta-burst stimulation.
What is the current status of trial NCT04058249?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-11-01. Estimated completion is 2021-12-20.
What interventions are being tested in trial NCT04058249?
The interventions under investigation include: Accelerated intermittent theta-burst stimulation over right DLPFC (DEVICE).
Who is sponsoring clinical trial NCT04058249?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.